MINODRONATE (cas 127657-42-5), a Newly Developed Nitrogen-Containing Bisphosphonate, Suppresses Melanoma Growth and Improves Survival in Nude Mice by Blocking Vascular Endothelial Growth Factor Signaling
-
Add time:08/17/2019 Source:sciencedirect.com
Angiogenesis, a process by which new vascular networks are formed from pre-existing capillaries, is required for tumors to grow, invade, and metastasize. Vascular endothelial growth factor (VEGF), a specific mitogen to endothelial cells, is a crucial factor for tumor angiogenesis. In this study, we investigated whether minodronate, a newly developed nitrogen-containing bisphosphonate, could inhibit melanoma growth and improve survival in nude mice by suppressing the VEGF signaling. We found here that minodronate inhibited melanoma growth and improved survival in nude mice by suppressing the tumor-associated angiogenesis and macrophage infiltration. Minodronate completely inhibited the VEGF-induced increase in DNA synthesis and tube formation in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation and Ras activation. Furthermore, minodronate inhibited the VEGF-induced expression of intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in endothelial cells. Minodronate decreased DNA synthesis and increased apoptotic cell death of cultured melanoma cells as well. Our present study suggests that minodronate might suppress melanoma growth and improve survival in nude mice by two independent mechanisms; one is by blocking the VEGF signaling in endothelial cells, and the other is by inducing apoptotic cell death of melanoma. The present study provides a novel potential therapeutic strategy for the treatment of melanoma.
We also recommend Trading Suppliers and Manufacturers of MINODRONATE (cas 127657-42-5). Pls Click Website Link as below: cas 127657-42-5 suppliers
Prev:MINODRONATE (cas 127657-42-5), a nitrogen-containing bisphosphonate, is a promising remedy for treating patients with diabetic retinopathy
Next:Substituent effects on the reaction mode between 2-hydroxybenzyl alcohol derivatives and MEM chloride: synthesis and mechanistic aspects of seven- and ten-membered benzo-fused O,O-acetals) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- MINODRONATE (cas 127657-42-5), a nitrogen-containing bisphosphonate, is a promising remedy for treating patients with diabetic retinopathy08/16/2019
- A double-blinded head-to-head trial of MINODRONATE (cas 127657-42-5) and alendronate in women with postmenopausal osteoporosis08/15/2019
- Comparison of effectiveness and safety of ibandronate and MINODRONATE (cas 127657-42-5) combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study08/14/2019
- Effects of MINODRONATE (cas 127657-42-5) on cortical bone response to mechanical loading in rats08/13/2019
- Combined treatment with MINODRONATE (cas 127657-42-5) and vitamin C increases bone mineral density and strength in vitamin C-deficient rats08/12/2019
- Effect of MINODRONATE (cas 127657-42-5) on the speed of sound of the calcaneus in postmenopausal women with an increased risk of fractures: A clinical practice-based observational study08/11/2019
- Monthly MINODRONATE (cas 127657-42-5) inhibits bone resorption to a greater extent than does monthly risedronate08/10/2019
- Initiation of Monthly MINODRONATE (cas 127657-42-5) Therapy at an Early Stage After Hip Fracture08/09/2019
- Influence on the bone mineral density and bone metabolism marker after the interruption and reinitiation of monthly MINODRONATE (cas 127657-42-5) therapy in postmenopausal women with osteoporosis08/08/2019


